News

• 2022.11.28 news
  Notice of Publication of Related Article on Artificial Intelligence (AI)-based Diabetes Treatment Support System
• 2022.10.31 news
  Supplementary Information on the Immune Checkpoint Inhibition by the PAI-1 inhibitor (RS5614)
• 2022.10.07 news
  Notice of Publication of the Results on Detection of Breast Cancer in Histopathological Micrographs Using Single-Shot Multi-box Detector (SSD)
• 2022.09.26 news
  Notice of Publication of the Result of Late Phase II Study for Chronic Myeloid Leukemia
• 2022.09.15 news
  Disposable Ultrafine Endoscope
• 2022.08.08 news
  Notice of Initiation of Phase III Study for Chronic Myeloid Leukemia
• 2022.01.01 news
  Renascience announces the establishment of Tohoku University RenaScience Open Innovation Lab (TREx)
• 2021.12.21 news
  Kahoku Shimpo published an article about the opening of our R&D center “TREx”.
• 2021.10.11 news
  The Cyclic Innovation for Clinical Empowerment (CiCLE) project of the Japan Agency for Medical Research and Development decided to continue supporting our clinical trial.
• 2021.10.04 news
  Our listing on the Tokyo Stock Exchange Mothers market and an article on the PAI-1 inhibitor RS5614 (for CML, COVID-19, etc.) were featured in The Chemical Daily.